RTA Laboratuvarlari Biyolojik (RTALB) — Long-term Investment Intensity

Latest as of December 2019: 28.7%

RTA Laboratuvarlari Biyolojik (RTALB) has a Long-term Investment Intensity of 28.7% as of December 2019. Long-term investments of TL28.19 Million represent 28.7% of total assets of TL98.16 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check RTALB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

28.7%
LT Investments / Total Assets

Long-term Investments

TL28.19 Million
TRY

Total Assets

TL98.16 Million
TRY

Country

Turkey
IS

RTA Laboratuvarlari Biyolojik Long-term Investment Intensity (2019–2019)

This chart shows how RTA Laboratuvarlari Biyolojik's Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the intensity stands at 28.7%, reflecting long-term investments of TL28.19 Million against total assets of TL98.16 Million TRY. Explore RTA Laboratuvarlari Biyolojik cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for RTA Laboratuvarlari Biyolojik (2019–2019)

The table below presents the year-by-year Long-term Investment Intensity for RTA Laboratuvarlari Biyolojik from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see RTALB market cap.

Year LT Investment Intensity LT Investments (TRY) Total Assets Change (pp)
2019 28.7% TL28.19 Million TL98.16 Million
pp = percentage points